blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4119134

EP4119134 - PHARMACEUTICAL COMPOSITION FOR USE IN INHIBITING THE INFECTIVITY OF BILAYER VIRUSES, TO TREAT ASSOCIATED DISEASES AND THEIR COMPLICATIONS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  14.07.2023
Database last updated on 07.10.2024
FormerThe application has been published
Status updated on  16.12.2022
Formerunknown
Status updated on  21.05.2022
Most recent event   Tooltip22.03.2024Change - prioritypublished on 24.04.2024  [2024/17]
Applicant(s)For all designated states
Monkam Nitcheu, Guy Faustin
Résidence les Clos d'Acajou
B32
97232 Le Lamentin / MQ
[2023/03]
Inventor(s)01 / see applicant
...
 [2023/03]
Representative(s)Sach, Greg Robert
Valet Patent Services Limited
c/o Caya 83713X
Am Börstig 5
96052 Bamberg / DE
[N/P]
Application number, filing date22315076.425.03.2022
[2023/03]
Priority number, datedeleted
[2024/17]
Former [2023/03]FR2021000314427.03.2021
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP4119134
Date:18.01.2023
Language:FR
[2023/03]
Search report(s)(Supplementary) European search report - dispatched on:EP21.12.2022
ClassificationIPC:A61K31/015, A61K31/045, A61K31/11, A61K31/12, A61K31/353, A61K31/575, A61P3/06, A61P3/10, A61P31/12, A61P31/14, A61P31/16, A61P31/18, A61P35/00
[2023/03]
CPC:
A61K31/015 (EP,CN,US); A61K31/56 (CN,US); A61K31/045 (EP);
A61K31/11 (EP,CN,US); A61K31/12 (EP,CN); A61K31/353 (EP,CN);
A61K31/575 (EP,CN); A61K45/06 (US); A61P29/00 (CN);
A61P3/04 (CN); A61P3/06 (EP,CN); A61P3/10 (EP,CN);
A61P31/04 (CN); A61P31/12 (EP,CN); A61P31/14 (EP,CN);
A61P31/16 (EP); A61P31/18 (EP); A61P33/00 (CN);
A61P35/00 (EP); A61P37/06 (CN) (-)
C-Set:
A61K31/015, A61K2300/00 (CN,EP);
A61K31/045, A61K2300/00 (EP);
A61K31/11, A61K2300/00 (EP,CN);
A61K31/12, A61K2300/00 (CN,EP);
A61K31/353, A61K2300/00 (EP,CN);
A61K31/56, A61K2300/00 (CN);
A61K31/575, A61K2300/00 (EP,CN)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/33]
Former [2023/03]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR HEMMUNG DER INFEKTIOSITÄT VON LIPID-DOPPELSCHICHTVIREN, ZUR BEHANDLUNG VON DAMIT VERBUNDENEN KRANKHEITEN UND DEREN KOMPLIKATIONEN[2023/03]
English:PHARMACEUTICAL COMPOSITION FOR USE IN INHIBITING THE INFECTIVITY OF BILAYER VIRUSES, TO TREAT ASSOCIATED DISEASES AND THEIR COMPLICATIONS[2023/03]
French:COMPOSITION PHARMACEUTIQUE DESTINÉE À INHIBER L'INFECTIOSITÉ DES VIRUS À BICOUCHE LIPIDIQUE, À TRAITER LES MALADIES ASSOCIÉES ET LEURS COMPLICATIONS[2023/03]
Examination procedure16.03.2023Loss of particular rights, legal effect: Priority
12.07.2023Examination requested  [2023/33]
12.07.2023Date on which the examining division has become responsible
18.07.2023Amendment by applicant (claims and/or description)
03.11.2023Despatch of communication of loss of particular rights: Priority 0001
Request for further processing for:The application is deemed to be withdrawn due to non-payment of the search fee
04.12.2022Request for further processing filed
04.12.2022Full payment received (date of receipt of payment)
Request granted
12.12.2022Decision despatched
The application is deemed to be withdrawn due to non-payment of the filing fee
04.12.2022Request for further processing filed
04.12.2022Full payment received (date of receipt of payment)
Request granted
12.12.2022Decision despatched
Fees paidRenewal fee
13.03.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]JPH0826980  (TSUMURA & CO);
 [Y]WO2012130893  (CENTRE NAT RECH SCIENT [FR], et al);
 [Y]WO2018127748  (MONKAM NITCHEU GUY FAUSTIN [FR]);
 [Y]EP3785709  (MONKAM NITCHEU GUY FAUSTIN [FR]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.